États-Unis · Plateformes & données · MarketBeat

BridgeBio Pharma (NASDAQ:BBIO) Stock Purchase Reported by Rep. Gilbert Ray Cisneros, Jr.

Publié par MarketBeat · États-Unis il y a 13 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO). In a filing disclosed on November 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in BridgeBio Pharma stock on October 27th. The trade o

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

BridgeBio Pharma (NASDAQ:BBIO) Stock Purchase Reported by Rep. Gilbert Ray Cisneros, Jr.

Résumé détaillé

À lire aussi

China approves Eli Lilly's GLP-1 weight-loss pill, giving it lead over Novo - report

The Best Uranium Stocks to Buy and Hold as Nuclear Power Expands

MT Højgaard Q3 2026 slides: recovery drives 12% revenue growth

China's Ministry of State Security thrust into the spotlight by Nvidia CEO affair

CampusQ launches ReportReady to turn self-assurance into proof

NVDA Stock Rout: Another Analyst Slashes Rating, Beijing Warns US Against Tech Curbs

BridgeBio Pharma (NASDAQ:BBIO) Stock Purchase Reported by Rep. Gilbert Ray Cisneros, Jr.

Résumé détaillé

Partager

À lire aussi

China approves Eli Lilly's GLP-1 weight-loss pill, giving it lead over Novo - report

The Best Uranium Stocks to Buy and Hold as Nuclear Power Expands

MT Højgaard Q3 2026 slides: recovery drives 12% revenue growth

China's Ministry of State Security thrust into the spotlight by Nvidia CEO affair

CampusQ launches ReportReady to turn self-assurance into proof

NVDA Stock Rout: Another Analyst Slashes Rating, Beijing Warns US Against Tech Curbs